LEADER 01267nam a2200289 i 4500 001 991003562659707536 005 20020503200155.0 008 000908s1958 it ||| | ita 035 $ab10524241-39ule_inst 035 $aEXGIL123050$9ExL 040 $aBiblioteca Interfacoltà$bita 082 0 $a804 111 2 $aConvegno internazionale di studi sul Rinascimento $n<5. ;$d1956 ;$cFirenze>$0392478 245 13$aIl mondo antico nel Rinascimento :$batti del 5. Convegno internaz. di studi sul Rinascimento :$bFirenze, Palazzo Strozzi, 2-6 IX 1956 /$cIstituto naz. di studi sul Rinascimento 260 $aFirenze :$bSansoni,$c1958 300 $a286 p. :$b12 tav. ;$c25 cm. 650 4$aArte classica - Imitazioni$ySec. 15.-16.$xCongressi$y1956 650 4$aLetteratura classica - Imitazioni$ySec. 15.-16.$xCongressi$y1956 650 4$aRinascimento$xCongressi$y1956 650 4$aUmanesimo$xCongressi$y1956 907 $a.b10524241$b02-04-14$c27-06-02 912 $a991003562659707536 945 $aLE002 804 CON 945 $aLE002 It. II F 14$g1$i2002000461025$lle002$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i10602902$z27-06-02 996 $aMondo antico nel Rinascimento$9136698 997 $aUNISALENTO 998 $ale002$b01-01-00$cm$da $e-$fita$git $h3$i1 LEADER 01468oam 2200397Ia 450 001 9910698724403321 005 20090423145856.0 035 $a(CKB)5470000002396614 035 $a(OCoLC)319065082 035 $a(EXLCZ)995470000002396614 100 $a20090423d2008 ua 0 101 0 $aeng 135 $auran||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aGuidance for industry$b[electronic resource] $eproviding regulatory submissions in electronic format, postmarketing indivudal case safety reports 210 1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research,$d[2008] 215 $a8 pages $cdigital, PDF file 300 $aTitle from PDF title page (viewed on Apr. 23, 2009). 300 $a"Draft guidance". 300 $a"June 2008." 517 $aGuidance for industry 606 $aDrug testing$zUnited States$vCase studies 606 $aElectronic filing systems$zUnited States 615 0$aDrug testing 615 0$aElectronic filing systems 712 02$aCenter for Drug Evaluation and Research (U.S.) 712 02$aCenter for Biologics Evaluation and Research (U.S.) 801 0$bGPO 801 1$bGPO 801 2$bGPO 906 $aBOOK 912 $a9910698724403321 996 $aGuidance for industry$93434577 997 $aUNINA